Publisher
Springer Science and Business Media LLC
Subject
Energy Engineering and Power Technology,Fuel Technology
Reference98 articles.
1. Zhou, Y. et al. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. Natl Sci. Rev. https://doi.org/10.1093/nsr/nwaa041 (2020).
2. Hamilton, J. A. GM-CSF in inflammation. J. Exp. Med. 217, e20190945 (2020).
3. Hamilton, J. A., Cook, A. D. & Tak, P. P. Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases. Nat. Rev. Drug. Discov. 16, 53–70 (2016).
4. Humanigen. FDA approves initiation of Humanigen’s phase III study of lenzilumab in COVID-19 patients. Humanigen https://www.humanigen.com/press/FDA-Approves-Initiation-of-Humanigen%E2%80%99s-Phase-III-Study-of-Lenzilumab-in-COVID-19-Patients (2020).
5. I-Mab Biopharma. I-Mab announces IND clearance from FDA for TJM2 to treat cytokine release syndrome (CRS) associated with severe coronavirus disease 19 (COVID-19). I-Mab Biopharma http://www.i-mabbiopharma.com/en/article-517.aspx (2020).
Cited by
192 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献